Gentamicin disposition in children with chronic renal failure

Area of Science:

• Pharmacokinetics
• Nephrology
• Pediatrics

Background:

• Gentamicin is a crucial antibiotic for treating bacterial infections in children.
• Chronic renal failure (CRF) can significantly alter drug disposition, impacting treatment efficacy and safety.
• Understanding gentamicin pharmacokinetics in pediatric CRF is essential for optimizing dosing regimens.

Purpose of the Study:

• To determine and compare gentamicin disposition in children with stable chronic renal failure (CRF) versus those with normal renal function (NRF).
• To identify pharmacokinetic parameters that are significantly affected by renal impairment.
• To establish a predictive relationship between renal function and gentamicin elimination.

Main Methods:

• Pharmacokinetic analysis of serum gentamicin concentrations over 8 hours post-intravenous loading dose.
• Comparison of gentamicin disposition parameters between pediatric CRF and NRF groups.
• Correlation analysis between creatinine clearance (Clcr) and gentamicin elimination rate constant (beta).

Main Results:

• Peak serum gentamicin concentrations were similar between CRF and NRF groups.
• Significant differences were observed in 8-hour serum concentrations, beta, t1/2 beta, plasma clearance, and k10 between the groups (P < 0.005).
• A linear relationship (beta = 0.033 + 0.003 X Clcr, P < 0.005, r = 0.97) was found, enabling prediction of gentamicin elimination from creatinine clearance.

Conclusions:

• Chronic renal failure significantly alters gentamicin disposition in children, particularly affecting its elimination rate.
• Creatinine clearance is a reliable predictor of gentamicin elimination in pediatric patients across a wide range of renal function.
• This predictive model can aid in individualized gentamicin dosing for children with varying degrees of renal impairment.